Publicacions en què col·labora amb Alberto Manuel Alvarez Barrientos (9)

2015

  1. A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells

    International Journal of Cancer, Vol. 136, Núm. 4, pp. E161-E172

2012

  1. Cell fusion reprogramming leads to a specific hepatic expression pattern during mouse bone marrow derived hepatocyte formation in vivo

    PLoS ONE, Vol. 7, Núm. 3

2008

  1. Deletion of the Met tyrosine kinase in liver progenitor oval cells increases sensitivity to apoptosis in vitro

    American Journal of Pathology, Vol. 172, Núm. 5, pp. 1238-1247

  2. Isolation and characterization of a putative liver progenitor population after treatment of fetal rat hepatocytes with TGF-beta

    Journal of Cellular Physiology, Vol. 215, Núm. 3, pp. 846-855

2007

  1. Negative regulation of Akt activity by p38α MAP kinase in cardiomyocytes involves membrane localization of PP2A through interaction with caveolin-1

    Cellular Signalling, Vol. 19, Núm. 1, pp. 62-74

  2. p38α MAPK can positively or negatively regulate Rac-1 activity depending on the presence of serum

    FEBS Letters, Vol. 581, Núm. 20, pp. 3819-3825

2006

  1. Autocrine production of TGF-β confers resistance to apoptosis after an epithelial-mesenchymal transition process in hepatocytes: Role of EGF receptor ligands

    Experimental Cell Research, Vol. 312, Núm. 15, pp. 2860-2871

  2. Hematopoietic mobilization in mice increases the presence of bone marrow-derived hepatocytes via in vivo cell fusion

    Hepatology, Vol. 43, Núm. 1, pp. 108-116

2004

  1. Source of early reactive oxygen species in the apoptosis induced by transforming growth factor-β in fetal rat hepatocytes

    Free Radical Biology and Medicine, Vol. 36, Núm. 1, pp. 16-26